chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, headache and fever was not reported. This report was non-serious. This case, from the same reporter is linked to 20210345602.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Musculoskeletal stiffness
Clinical narrative: STIFFNESS IN HANDS, FEET AND LEG; CHILLS; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, and batch number: 1802068 expiry: 25-MAY-2021) dose was not reported, administered on 10-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced headache. On 18-MAR-2021, the subject experienced stiffness in hands, feet and leg. On 18-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stiffness in hands, feet and leg, chills, and headache on 19-MAR-2021. This report was non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Vomiting
Clinical narrative: VOMITING; HEADACHE; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's past medical history included dental extraction, and concurrent conditions included neuropathy, and other pre-existing medical conditions included the patient had no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: 25-MAY-2021) dose was not reported, administered on 12-MAR-2021 in the right arm for prophylactic vaccination. Concomitant medications included ibuprofen for pain, and amoxicillin. On 12-MAR-2021, the subject experienced headache. On 12-MAR-2021, the subject experienced nausea. On 12-MAR-2021, the subject experienced fatigue. On 13-MAR-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from vomiting, and had not recovered from headache, fatigue, and nausea. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Fatigue, Hypersomnia, Muscle spasms
Clinical narrative: VERY SLEEPY/SLEEPING WHILE DRIVING,DOZED OFF AT WORK; MUSCLE CRAMP/PAIN IN HER RIGHT SIDE,ON HER RIGHT CALF; BACK(SEVERE SHARP PAIN)/BURNING SENSATION; FATIGUE(WAS NOT ABLE TO GET OUT OF BED); CHEST PAIN ON THE LEFT SIDE; FATIGUE (VERY SLEEPY); This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, cholesterol, and smoker, and other pre-existing medical conditions included patient had no drug allergy. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070,  expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 at is right arm  for prophylactic vaccination. No concomitant medications were reported. On 01-JAN-2021, Laboratory data included: COVID-19 PCR test (NR: not provided) NEGATIVE. On 13-MAR-2021, the subject experienced fatigue (very sleepy). On 18-MAR-2021, the subject experienced chest pain on the left side. On an unspecified date, the subject experienced very sleepy/sleeping while driving, dozed off at work, muscle cramp/pain in her right side, on her right calf, back (severe sharp pain) /burning sensation, and fatigue (was not able to get out of bed). Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chest pain on the left side on 18-MAR-2021, and had not recovered from fatigue (very sleepy), fatigue(was not able to get out of bed), very sleepy/sleeping while driving, dozed off at work, muscle cramp/pain in her right side,  on her right calf, and back(severe sharp pain)/burning sensation. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: VERY SLEEPY/SLEEPING WHILE DRIVING,DOZED OFF AT WORK; MUSCLE CRAMP/PAIN IN HER RIGHT SIDE,ON HER RIGHT CALF; BACK(SEVERE SHARP PAIN)/BURNING SENSATION; FATIGUE(WAS NOT ABLE TO GET OUT OF BED); CHEST PAIN ON THE LEFT SIDE; FATIGUE (VERY SLEEPY); This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, cholesterol, and smoker, and other pre-existing medical conditions included patient had no drug allergy. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070,  expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 at is right arm  for prophylactic vaccination. No concomitant medications were reported. On 01-JAN-2021, Laboratory data included: COVID-19 PCR test (NR: not provided) NEGATIVE. On 13-MAR-2021, the subject experienced fatigue (very sleepy). On 18-MAR-2021, the subject experienced chest pain on the left side. On an unspecified date, the subject experienced very sleepy/sleeping while driving, dozed off at work, muscle cramp/pain in her right side, on her right calf, back (severe sharp pain) /burning sensation, and fatigue (was not able to get out of bed). Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chest pain on the left side on 18-MAR-2021, and had not recovered from fatigue (very sleepy), fatigue(was not able to get out of bed), very sleepy/sleeping while driving, dozed off at work, muscle cramp/pain in her right side,  on her right calf, and back(severe sharp pain)/burning sensation. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Sinus headache
Clinical narrative: SINUS HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 18-MAR-2021, the subject experienced sinus headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sinus headache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Myalgia, Pain of skin, Skin irritation
Clinical narrative: BROKE OUT  IN SWEATS; VOMITING; CHILLS; SKIN SORE TO TOUCH; HOT/SWEATY; TENDER SKIN; MUSCLE ACHES; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-smoker, and non-alcoholic, and other pre-existing medical conditions included the patient had no known drug allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: 20/MAR/2021) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, the subject experienced broke out in sweats. On 20-MAR-2021, the subject experienced vomiting. On 20-MAR-2021, the subject experienced chills. On 20-MAR-2021, the subject experienced skin sore to touch. On 20-MAR-2021, the subject experienced hot/sweaty. On 20-MAR-2021, the subject experienced tender skin. On 20-MAR-2021, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting on 20-MAR-2021, and had not recovered from broke out in sweats, chills, skin sore to touch, hot/sweaty, tender skin, and muscle aches. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: BROKE OUT  IN SWEATS; VOMITING; CHILLS; SKIN SORE TO TOUCH; HOT/SWEATY; TENDER SKIN; MUSCLE ACHES; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-smoker, and non-alcoholic, and other pre-existing medical conditions included the patient had no known drug allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: 20/MAR/2021) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, the subject experienced broke out in sweats. On 20-MAR-2021, the subject experienced vomiting. On 20-MAR-2021, the subject experienced chills. On 20-MAR-2021, the subject experienced skin sore to touch. On 20-MAR-2021, the subject experienced hot/sweaty. On 20-MAR-2021, the subject experienced tender skin. On 20-MAR-2021, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting on 20-MAR-2021, and had not recovered from broke out in sweats, chills, skin sore to touch, hot/sweaty, tender skin, and muscle aches. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Hypoaesthesia
Clinical narrative: NUMBNESS IN THE RIGHT LEG; RIGHT LEG A LITTLE HOT; TIRED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced numbness in the right leg. On MAR-2021, the subject experienced right leg a little hot. On MAR-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the numbness in the right leg, right leg a little hot and tired was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasopharyngitis
Clinical narrative: COLD; TIREDNESS/ FATIGUE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included paracetamol for prophylactic. On an unspecified date, the subject experienced cold, and tiredness/ fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tiredness/ fatigue and cold was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Injection site pain, Somnolence, Thinking abnormal
Clinical narrative: LIGHT-HEADED; NOT CLEAR-HEADED; HEADACHE; LITTLE SORE AT INJECTION SITE; SLEEPY; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, cholesterol, and blood pressure, and other pre-existing medical conditions included the patient had no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: 25/MAY/2021) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On 19-MAR-2021, the subject experienced sleepy. On 20-MAR-2021, the subject experienced light-headed. On 20-MAR-2021, the subject experienced not clear-headed. On 20-MAR-2021, the subject experienced headache. On 20-MAR-2021, the subject experienced little sore at injection site. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sleepy on 19-MAR-2021, and had not recovered from light-headed, headache, not clear-headed, and little sore at injection site. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Dizziness, Headache, Insomnia
Clinical narrative: FEVER; NAUSEA; HEADACHE; HEART WAS RACING; TROUBLE SLEEPING; BODY HURTING; BACK HURTING; LIGHTHEADEDNESS; SORE ARM; This spontaneous report received from a patient concerned a 60 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 at 10:00 on left arm for prophylactic vaccination . No concomitant medications were reported. On 19-MAR-2021, the subject experienced heart was racing. On 19-MAR-2021, the subject experienced trouble sleeping. On 19-MAR-2021, the subject experienced body hurting. On 19-MAR-2021, the subject experienced back hurting. On 19-MAR-2021, the subject experienced lightheadedness. On 19-MAR-2021, the subject experienced sore arm. On 19-MAR-2021 at 22:00, the subject experienced fever. On 19-MAR-2021, the subject experienced nausea. On 19-MAR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 102 F. Treatment medications included: paracetamol. On 20-MAR-2021 01:00, treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart was racing, and trouble sleeping on 21-MAR-2021, and nausea, was recovering from body hurting, and back hurting, and had not recovered from sore arm, fever, headache, and lightheadedness. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity, Palpitations, Pyrexia
Clinical narrative: FEVER; NAUSEA; HEADACHE; HEART WAS RACING; TROUBLE SLEEPING; BODY HURTING; BACK HURTING; LIGHTHEADEDNESS; SORE ARM; This spontaneous report received from a patient concerned a 60 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 at 10:00 on left arm for prophylactic vaccination . No concomitant medications were reported. On 19-MAR-2021, the subject experienced heart was racing. On 19-MAR-2021, the subject experienced trouble sleeping. On 19-MAR-2021, the subject experienced body hurting. On 19-MAR-2021, the subject experienced back hurting. On 19-MAR-2021, the subject experienced lightheadedness. On 19-MAR-2021, the subject experienced sore arm. On 19-MAR-2021 at 22:00, the subject experienced fever. On 19-MAR-2021, the subject experienced nausea. On 19-MAR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 102 F. Treatment medications included: paracetamol. On 20-MAR-2021 01:00, treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart was racing, and trouble sleeping on 21-MAR-2021, and nausea, was recovering from body hurting, and back hurting, and had not recovered from sore arm, fever, headache, and lightheadedness. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: CHILLS; FEVER; NAUSEA; FATIGUE; This spontaneous report received from a patient via a company representative concerned an adult female. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and non alcohol user, and other pre-existing medical conditions included the patient had no history of drug abuse/ illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 13-MAR-2021, the subject experienced chills. On 13-MAR-2021, the subject experienced fever. On 13-MAR-2021, the subject experienced nausea. On 13-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, fever, nausea, and fatigue on 15-MAR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Cough, Fatigue, Nasal congestion, Pyrexia
Clinical narrative: CONGESTION; COUGH; FEVER; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, and batch number: 1802072 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 to the Left Arm for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the subject experienced fatigue. On 18-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.4. On 18-MAR-2021 05:30, the subject experienced congestion. On 18-MAR-2021 05:30, the subject experienced cough. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue, and the outcome of congestion, cough and fever was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vomiting
Clinical narrative: FEVER; VOMITED; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included atrial fibrillation, and triple stroke in his brain, and concurrent conditions included hypertension, high cholesterol, congestive heart failure, seafood allergy, no alcohol use, and non smoker, and other pre-existing medical conditions included the patient had no known allergies. the patient had no history of drug abuse/illicit drug use.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070 expiry: UNKNOWN) dose was not reported, administered on 17-MAR-2021 13:00 to left deltoid for prophylactic vaccination. No concomitant medications were reported. On 18-MAR-2021, the subject experienced vomited. On 19-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomited on 18-MAR-2021, and had not recovered from fever. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: BODY CHILLS; HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 19-MAR-2021, the subject experienced body chills. On 19-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body chills and headache was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned an adult male. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) once a total dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 20-MAR-2021, the subject experienced chills. On 20-MAR-2021, the subject experienced headache. On 20-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headache, fever, and chills. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: COLD; CHILLS; FEVER; FATIGUE; THROBBING HEADACHE LIGHT SENSITIVE/BLURRY HEADACHE; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 13:00 for prophylactic vaccination on right arm. No concomitant medications were reported. On an unspecified date, the subject experienced cold, chills, fever, fatigue, throbbing headache light sensitive/blurry headache, and injection site pain. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, fever, fatigue, cold, throbbing headache light sensitive/blurry headache and injection site pain was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia
Clinical narrative: COLD; CHILLS; FEVER; FATIGUE; THROBBING HEADACHE LIGHT SENSITIVE/BLURRY HEADACHE; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 13:00 for prophylactic vaccination on right arm. No concomitant medications were reported. On an unspecified date, the subject experienced cold, chills, fever, fatigue, throbbing headache light sensitive/blurry headache, and injection site pain. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, fever, fatigue, cold, throbbing headache light sensitive/blurry headache and injection site pain was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Oropharyngeal pain, Pain
Clinical narrative: SEVER BODY ACHE; CHILLS; THROAT HURTS AND DRY; HEADACHE; DIZZINESS; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included psoriasis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 16:00 on left arm for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced fever. On 19-MAR-2021 17:00, the subject experienced dizziness. On 19-MAR-2021 17:00, the subject experienced headache. On 20-MAR-2021, the subject experienced throat hurts and dry. On 20-MAR-2021 01:00, the subject experienced sever body ache. On 20-MAR-2021 01:00, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 20-MAR-2021 11:00, was recovering from sever body ache, and the outcome of headache, fever, dizziness and throat hurts and dry was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: SEVER BODY ACHE; CHILLS; THROAT HURTS AND DRY; HEADACHE; DIZZINESS; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included psoriasis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 16:00 on left arm for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced fever. On 19-MAR-2021 17:00, the subject experienced dizziness. On 19-MAR-2021 17:00, the subject experienced headache. On 20-MAR-2021, the subject experienced throat hurts and dry. On 20-MAR-2021 01:00, the subject experienced sever body ache. On 20-MAR-2021 01:00, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 20-MAR-2021 11:00, was recovering from sever body ache, and the outcome of headache, fever, dizziness and throat hurts and dry was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pyrexia, Throat irritation, Vertigo
Clinical narrative: BURNING SENSATION ON THE BACK OF THE THROAT; ACHE IN JOINTS; LOW GRADE FEVER; MUSCLE ACHES; VERTIGO; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced vertigo. On 12-MAR-2021, the subject experienced burning sensation on the back of the throat. On 12-MAR-2021, the subject experienced ache in joints. On 12-MAR-2021, the subject experienced low grade fever. On 12-MAR-2021, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vertigo, low grade fever, ache in joints, muscle aches and burning sensation on the back of the throat was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Muscle spasms
Clinical narrative: SWEATING; CHILLS; NAUSEOUS; FATIGUE; HEADACHE; CRAMPS IN LEGS; ACHINESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 18-MAR-2021, the subject experienced cramps in legs. On 18-MAR-2021, the subject experienced achiness. On 18-MAR-2021, the subject experienced chills. On 18-MAR-2021, the subject experienced nauseous. On 18-MAR-2021, the subject experienced fatigue. On 18-MAR-2021, the subject experienced headache. On 19-MAR-2021, the subject experienced sweating. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cramps in legs, achiness, chills, nauseous, fatigue, and headache on MAR-2021, and sweating on 19-MAR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pain
Clinical narrative: SWEATING; CHILLS; NAUSEOUS; FATIGUE; HEADACHE; CRAMPS IN LEGS; ACHINESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 18-MAR-2021, the subject experienced cramps in legs. On 18-MAR-2021, the subject experienced achiness. On 18-MAR-2021, the subject experienced chills. On 18-MAR-2021, the subject experienced nauseous. On 18-MAR-2021, the subject experienced fatigue. On 18-MAR-2021, the subject experienced headache. On 19-MAR-2021, the subject experienced sweating. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cramps in legs, achiness, chills, nauseous, fatigue, and headache on MAR-2021, and sweating on 19-MAR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Cough, Dizziness, Fatigue, Headache, Influenza like illness
Clinical narrative: FACIAL SWELLING; DRY COUGH; DIZZY; FLU LIKE SYMPTOMS; HEADACHE; FEVER; TIREDNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included edema, copd, asthma, htn, seizure, sleep apnea, and hashimotos. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 16-MAR-2021 on right arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced dizzy. On MAR-2021, the subject experienced flu like symptoms. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced tiredness. On 20-MAR-2021, the subject experienced facial swelling. On 20-MAR-2021, the subject experienced dry cough. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, facial swelling, dry cough, fever, tiredness, dizzy and flu like symptoms was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Swelling face
Clinical narrative: FACIAL SWELLING; DRY COUGH; DIZZY; FLU LIKE SYMPTOMS; HEADACHE; FEVER; TIREDNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included edema, copd, asthma, htn, seizure, sleep apnea, and hashimotos. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 16-MAR-2021 on right arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced dizzy. On MAR-2021, the subject experienced flu like symptoms. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced tiredness. On 20-MAR-2021, the subject experienced facial swelling. On 20-MAR-2021, the subject experienced dry cough. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, facial swelling, dry cough, fever, tiredness, dizzy and flu like symptoms was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Headache, Myalgia, Pain in extremity
Clinical narrative: MUSCLE PAIN; PAIN IN LOWER LEGS; HEADACHE; BACK PAIN; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination.  The batch number is not reported and has been requested . No concomitant medications were reported. On 19-MAR-2021, the subject experienced muscle pain. On 19-MAR-2021, the subject experienced pain in lower legs. On 19-MAR-2021, the subject experienced headache. On 19-MAR-2021, the subject experienced back pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the muscle pain, pain in lower legs, headache and back pain was not reported. This report was non-serious.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure measurement, Chills, Cold sweat, Hypotension
Clinical narrative: EXTREME BREAK OUT OF COLD SWEAT; BEE STING-LIKE PAIN; NERVE PAIN; LOW BLOOD PRESSURE; IRRITABLE; RASH TROUGHOUT BODY; CHILLS; SWELLING AT SITE OF INJECTION; FEVER; NO STRENGTH TO STAND UP; ITCHING; BODY ACHES; This spontaneous report received from a patient concerned a 68 year old female. The patient's height, and weight were not reported. The patient's past medical history included sepsis, and concurrent conditions included no alcohol use, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 12:30, in the left arm, for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced body aches. On MAR-2021, the subject experienced itching. On MAR-2021, the subject experienced no strength to stand up. On 18-MAR-2021, the subject experienced extreme break out of cold sweat. On 18-MAR-2021, the subject experienced bee sting-like pain. On 18-MAR-2021, the subject experienced nerve pain. On 18-MAR-2021, the subject experienced low blood pressure. On 18-MAR-2021, the subject experienced irritable. On 18-MAR-2021, the subject experienced rash throughout body. On 18-MAR-2021, the subject experienced chills. On 18-MAR-2021, the subject experienced swelling at site of injection. On 18-MAR-2021, the subject experienced fever. Laboratory data included: Blood pressure (NR: not provided) Low. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 19-MAR-2021, had not recovered from extreme break out of cold sweat, chills, low blood pressure, swelling at site of injection, rash throughout body, bee sting-like pain, nerve pain, and irritable, and the outcome of itching, no strength to stand up and body aches was not reported. This report was non-serious.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Irritability, Neuralgia, Pain, Pruritus
Clinical narrative: EXTREME BREAK OUT OF COLD SWEAT; BEE STING-LIKE PAIN; NERVE PAIN; LOW BLOOD PRESSURE; IRRITABLE; RASH TROUGHOUT BODY; CHILLS; SWELLING AT SITE OF INJECTION; FEVER; NO STRENGTH TO STAND UP; ITCHING; BODY ACHES; This spontaneous report received from a patient concerned a 68 year old female. The patient's height, and weight were not reported. The patient's past medical history included sepsis, and concurrent conditions included no alcohol use, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 12:30, in the left arm, for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced body aches. On MAR-2021, the subject experienced itching. On MAR-2021, the subject experienced no strength to stand up. On 18-MAR-2021, the subject experienced extreme break out of cold sweat. On 18-MAR-2021, the subject experienced bee sting-like pain. On 18-MAR-2021, the subject experienced nerve pain. On 18-MAR-2021, the subject experienced low blood pressure. On 18-MAR-2021, the subject experienced irritable. On 18-MAR-2021, the subject experienced rash throughout body. On 18-MAR-2021, the subject experienced chills. On 18-MAR-2021, the subject experienced swelling at site of injection. On 18-MAR-2021, the subject experienced fever. Laboratory data included: Blood pressure (NR: not provided) Low. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 19-MAR-2021, had not recovered from extreme break out of cold sweat, chills, low blood pressure, swelling at site of injection, rash throughout body, bee sting-like pain, nerve pain, and irritable, and the outcome of itching, no strength to stand up and body aches was not reported. This report was non-serious.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: EXTREME BREAK OUT OF COLD SWEAT; BEE STING-LIKE PAIN; NERVE PAIN; LOW BLOOD PRESSURE; IRRITABLE; RASH TROUGHOUT BODY; CHILLS; SWELLING AT SITE OF INJECTION; FEVER; NO STRENGTH TO STAND UP; ITCHING; BODY ACHES; This spontaneous report received from a patient concerned a 68 year old female. The patient's height, and weight were not reported. The patient's past medical history included sepsis, and concurrent conditions included no alcohol use, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 12:30, in the left arm, for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced body aches. On MAR-2021, the subject experienced itching. On MAR-2021, the subject experienced no strength to stand up. On 18-MAR-2021, the subject experienced extreme break out of cold sweat. On 18-MAR-2021, the subject experienced bee sting-like pain. On 18-MAR-2021, the subject experienced nerve pain. On 18-MAR-2021, the subject experienced low blood pressure. On 18-MAR-2021, the subject experienced irritable. On 18-MAR-2021, the subject experienced rash throughout body. On 18-MAR-2021, the subject experienced chills. On 18-MAR-2021, the subject experienced swelling at site of injection. On 18-MAR-2021, the subject experienced fever. Laboratory data included: Blood pressure (NR: not provided) Low. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 19-MAR-2021, had not recovered from extreme break out of cold sweat, chills, low blood pressure, swelling at site of injection, rash throughout body, bee sting-like pain, nerve pain, and irritable, and the outcome of itching, no strength to stand up and body aches was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Fatigue, Muscle spasms, Pain
Clinical narrative: MUSCLE CRAMPS ON BOTH LEGS AFTER WORKING OUT; UPSET STOMACH; BODY ACHES; LOW ENERGY; VERY TIRED; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included lactose intolerant. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced upset stomach. On 12-MAR-2021, the subject experienced body aches. On 12-MAR-2021, the subject experienced low energy. On 12-MAR-2021, the subject experienced very tired. On 15-MAR-2021, the subject experienced muscle cramps on both legs after working out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from upset stomach, body aches, low energy, and very tired on 14-MAR-2021, and had not recovered from muscle cramps on both legs after working out. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Decreased immune responsiveness, Limb injury
Clinical narrative: FOOT INJURY; POSSIBLE DECREASED IMMUNE RESPONSE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number is not reported and is requested. No concomitant medications were reported. On 14-MAR-2021, the subject experienced foot injury. On 14-MAR-2021, the subject experienced possible decreased immune response. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the foot injury and possible decreased immune response was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, Laboratory data included: Body temperature (NR: not provided) 98.9 F. On 18-MAR-2021, the subject experienced fever. On 19-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 101.3 F, Approx 99. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Rash, SARS-CoV-2 test
Clinical narrative: SMALL BUMP; TIREDNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included type b diabetes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1080529 expiry: UNKNOWN) dose was not reported, administered on left arm on 16-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2020, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. On 16-MAR-2021, the subject experienced tiredness. On 17-MAR-2021, the subject experienced small bump. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tiredness, and had not recovered from small bump. This report was non-serious.
Age: 80.0
Sex: U
Vaccine: COVID19
Symptoms: Tongue discomfort
Clinical narrative: FEELT LIKE BURNED TONGUE WHICH WAS DESCRIBE AS FELT SOMETHING HOT ON TONGUE; This spontaneous report received from a patient concerned an 80 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 07-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced feelt like burned tongue which was describe as felt something hot on tongue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of felt like burned tongue which was describe as felt something hot on tongue was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pain, Pyrexia
Clinical narrative: BODY ACHES; MIGRAINE; FEVER/BURNING UP; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 18-MAR-2021 10:40 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 18-MAR-2021 14:00, the subject experienced body aches. On 18-MAR-2021 14:00, the subject experienced migraine. On 18-MAR-2021 14:00, the subject experienced fever/burning up. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, migraine, and fever/burning up. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling
Clinical narrative: HIP SWELLING; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included chronic obstructive pulmonary disease, lupus, ex smoker, non alcoholic, penicillin allergy, and coal tar product allergy, and other pre-existing medical conditions included patient had no history of drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: 25-MAY-2021) dose was not reported, administered on 10-MAR-2021 14:55 at right arm for prophylactic vaccination. Concomitant medications included meloxicam for right hip replacement surgery. On 13-MAR-2021, the subject experienced hip swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hip swelling. This report was non-serious.